Summary of the Boston Children’s Hospital review on melatonin Use in Pediatrics
This review, published in the World Journal of Pediatrics on April 30, 2025, examines the increasing use of melatonin supplements in children and adolescents and highlights significant concerns regarding its safety, efficacy, and regulation.
Key Findings:
* Rising Use & Limited Data: Melatonin use has dramatically increased, notably in countries where it’s available over-the-counter, but long-term data on its effects are limited.
* Effective for Neurodevelopmental Disorders: Strong evidence supports short-term effectiveness for children with neurodevelopmental disorders (autism, ADHD) in improving sleep onset, duration, and caregiver quality of life.
* Sparse Evidence for Typically Developing Children: evidence for use in typically developing children is weak, with most studies being short-term and focused on older children.
* Safety Concerns:
* Inconsistent Product Quality: Commercial melatonin products often have inaccurate labeling, with discrepancies between stated and actual melatonin content, and sometimes contain unintended compounds like serotonin.
* Accidental Ingestion: poison control data shows a sharp rise in accidental ingestions, especially in young children due to appealing formulations (gummies) and improper storage.
* Long-Term Effects Unknown: Long-term effects on puberty, immune function, metabolism, and neurological advancement are largely unknown.
* Melatonin is a Hormone: The review stresses that melatonin is a biologically active hormone,not a benign supplement.
Recommendations:
* Prioritize Behavioral Interventions: Behavioral sleep interventions (consistent routines, reduced screen time) should be the first-line treatment for childhood insomnia.
* Medical Supervision: When melatonin is considered, it should be used at the lowest effective dose, for the shortest duration, and only under medical supervision.
* Improved Regulation: Ther is an urgent need for better regulation of pediatric sleep supplements.
* Education: Clinicians and caregivers need to understand melatonin’s role as a hormone and the potential risks of unsupervised use.
in essence, the review cautions against viewing melatonin as a speedy fix for childhood sleep problems and emphasizes the need for a more cautious, evidence-based approach.
DOI: 10.1007/s12519-025-00896-5
Journal: World Journal of Pediatrics (https://link.springer.com/journal/12519)
Related reading